Definitive Healthcare (DH) Price to Sales (2021 - 2026)

Definitive Healthcare (DH) has reported Price to Sales for 6 consecutive years, with 1.61 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Sales fell 82.53% year-over-year to 1.61; the trailing twelve-month figure through Jun 2026 stood at 0.38 (down 83.3% YoY), and the FY2025 full-year result was 1.69, down 32.3% from the prior year.
• Price to Sales retreated to 1.61 in Q2 2026 per DH's latest filing, from 2.32 in the prior quarter.
• Across five years, Price to Sales topped out at 75.05 in Q1 2022 and bottomed at 1.61 in Q2 2026.
• Historically, Price to Sales has averaged 20.13 across 5 years, with a median of 14.56 in 2023.
• The sharpest annual moves came in 2023 and 2026: Price to Sales rose 20.32% in 2023, then sank 82.53% in 2026.
• Over 5 years, Price to Sales stood at 19.51 in 2022, then grew by 20.32% to 23.48 in 2023, then sank by 56.91% to 10.12 in 2024, then slumped by 34.37% to 6.64 in 2025, then tumbled by 75.82% to 1.61 in 2026.
• According to Business Quant data, Price to Sales over the past three periods registered 1.61, 2.32, and 6.64 for Q2 2026, Q1 2026, and Q4 2025 respectively.